Biocompatible implants and methods of making and attaching the same

• US 8,852,290 B2
• Filed: 03/03/2008
• Issued: 10/07/2014
• Est. Priority Date: 03/02/2007
• Status: Active Grant

• Current Assignee: Doheny Eye Institute
• Original Assignee: Doheny Eye Institute
• Inventors: Rowley, Adrian P., Laude, Lucien D., Humayun, Mark S., Weiland, James D., Lotfi, Atoosa, Markland, Francis S. Jr.
• Primary Examiner(s): MASHACK, MARK F
• Application Number:
  US12/041,651
• Publication Number:
  US 20080306611A1
• Time in Patent Office: 2,409 Days
• Field of Search: 424/422, 623/1.11, 623/23.72, 623/4.1, 623 511- 516, 623 611- 664, 427/2.24, 524/588, 428/318.4, 264/482, 204/157.15
• US Class Current: 623/23.74
• CPC Class Codes: A61F 2/148 Implantation instruments specially adapted therefor
• CPC Class Codes: A61L 2400/18 Modification of implant surfaces in order to improve biocompatibility, cell growth, fixation of biomolecules, e.g. plasma treatment
• CPC Class Codes: A61L 27/34 Macromolecular materials
• CPC Class Codes: A61L 27/50 Materials characterised by their function or physical properties , e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
• CPC Class Codes: A61N 1/0543 Retinal electrodes
• CPC Class Codes: A61N 1/36046 of the eye
• CPC Class Codes: C08L 89/00 Compositions of proteins; Compositions of derivatives thereof foodstuff preparations A23J3/00

Abstract

The invention provides a biocompatible silicone implant that can be securely affixed to living tissue through interaction with integral membrane proteins (integrins). A silicone article containing a laser-activated surface is utilized to make the implant. One example is an implantable prosthesis to treat blindness caused by outer retinal degenerative diseases. The device bypasses damaged photoreceptors and electrically stimulates the undamaged neurons of the retina. Electrical stimulation is achieved using a silicone microelectrode array (MEA). A safe, protein adhesive is used in attaching the MEA to the retinal surface and assist in alleviating focal pressure effects. Methods of making and attaching such implants are also provided.

Claims

1. A silicone article treated with a biocompatible compound that facilitates bonding to living tissue, comprising:

a silicone substrate having (i) an original surface plane;

(ii) an ablated and recessed first activated surface formed by irradiation with laser light at a wavelength and power sufficient to eject organic species from the silicone substrate by breaking Si—

C bonds of the substrate below the original surface plane, the first activated surface being below the original surface plane; and

(iii) an unrecessed second activated surface, adjacent the first surface, having thereon an adherent layer comprised of the ejected organic species; and

at least one compound capable of binding to one or more integrins, coupled to the substrate.

2. A silicone article as recited in claim 1, wherein the compound capable of binding to one or more integrins comprises an arginine-glycine-aspartate (RGD) peptide, or a protein containing at least one RGD segment.

3. A silicone article as recited in claim 1, wherein the compound capable of binding to one or more integrins comprises an extracellular matrix (ECM) protein.

4. A silicone article as recited in claim 3, wherein the ECM protein is selected from the group consisting of fibronectin, laminin, and collagen.

5. A silicone article as recited in claim 1, wherein the compound capable of binding to one or more integrins comprises a non-ECM protein.

6. A silicone article as recited in claim 5, wherein the non-ECM protein comprises contortrostatin or vicrostatin.

7. A silicone article as recited in claim 1, wherein the article comprises or is part of an implantable medical device.

8. A silicone article as recited in claim 1, wherein the article is an epiretinal visual prosthesis.

9. A silicone article as recited in claim 1, wherein the wavelength and the power are selected such that the laser light preserves Si—

O bonds in the substrate.

10. A silicone article as recited in claim 1, wherein the wavelength and the power are selected such that the laser light preserves Si—

O bonds in the substrate.

11. A silicone article as recited in claim 1, wherein the recessed first activated surface is 10 microns or more below the original surface plane.

12. A biocompatible, implantable prosthesis, comprising:

an implantable prosthesis partially or completely covered by a silicone having (i) an original surface plane;

(ii) an ablated and recessed first activated surface having been irradiated with laser light at a wavelength and power sufficient to eject organic species from the silicone substrate by breaking Si—

C bonds of the substrate below the original surface plane, the first activated surface being below the original surface plane; and

(iii) an unrecessed second activated surface, adjacent the first surface, having thereon an adherent layer comprised of the ejected organic species; and

at least one biocompatible compound capable of binding to one or more integrins, coupled to at least one activated surface.

13. A biocompatible, implantable prosthesis as recited in claim 12, wherein the implantable prosthesis comprises a microelectrode array.

14. A biocompatible, implantable prosthesis as recited in claim 12, wherein the biocompatible compound capable of binding to one or more integrins comprises an arginine-glycine-aspartate (RGD) peptide, or a protein containing at least one RGD segment.

15. A biocompatible, implantable prosthesis as recited in claim 14, wherein the compound capable of binding to one or more integrins comprises an extracellular matrix (ECM) protein.

16. A biocompatible, implantable prosthesis as recited in claim 15, wherein the ECM protein is selected from the group consisting of fibronectin, laminin, and collagen.

17. A biocompatible, implantable prosthesis as recited in claim 14, wherein the compound capable of binding to one or more integrins comprises a non-ECM protein.

18. A biocompatible, implantable prosthesis as recited in claim 17, wherein the non-ECM protein is selected from the group consisting of contortrostatin and vicrostatin.

19. A silicone article as recited in claim 12, wherein the wavelength and the power are selected such that the laser light preserves Si—

O bonds in the substrate.

20. A silicone article as recited in claim 12, wherein the wavelength and the power are selected such that the laser light preserves Si—

O bonds in the substrate.

21. A silicone article as recited in claim 12, wherein the recessed first activated surface is 10 microns or more below the original surface plane.

22. A method of making a biocompatible, implantable prosthesis, comprising:

providing an implantable prosthesis;

partially or completely covering the implantable prosthesis with a silicone having an original surface plane;

irradiating the silicone with laser light at a wavelength and power sufficient to eject organic species from the silicone by breaking Si—

C bonds of the silicone below the original surface plane, thereby forming a recessed first activated surface beneath the original surface plane;

forming an adherent layer on an unrecessed second activated surface, adjacent the first activate surface, with the ejected organic species; and

coupling at least one biocompatible compound capable of binding to one or more integrins to at least one activated surface.

23. A method as recited in claim 22, wherein the silicone coats the implantable prosthesis.

24. A method as recited in claim 22, wherein the silicone is provided as a jacket covering the implantable prosthesis.

25. A method as recited in claim 22, wherein the wavelength and the power are selected such that the laser light preserves Si—

O bonds in the substrate.

26. A method as recited in claim 22, wherein the recessed first activated surface is 10 microns or more below the original surface plane.